FDA applicant
Sangui Biotech, Inc.
FDA records 5 decisions for Sangui Biotech, Inc. (Santa Ana, CA) from 1997 to 2000: 5 510(k) clearances. Most are in product codes CKG (Radioimmunoassay, Acth) and CEW (Radioimmunoassay, Parathyroid Hormone). 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Sangui Biotech, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Sangui Biotech, Inc. since 2007.
Recalls per year
1in 2016
2007high 1 (2014) · low 0 (2007)2026
Class I Class II/III not classified
Planning a device like Sangui Biotech, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report